A shadow market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.
Experimental Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.
Learning About Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to users administering substances of unknown origin.
Some professionals stated the demand for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.
Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, advertising, and customer laws, risking fines, prosecution or imprisonment.
Service Response and Material Removal
Based on the social media company, the platform has taken down problematic material and banned related keywords and search suggestions. The organization said it was dedicated to keeping the service safe and investing in strengthening compliance measures.
Online Trading Operations
Investigations also discovered groups with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of members, populated with photos of slimming results, glowing reviews and detailed guides for mixing or injecting at home.
Within minutes of entering one group, a vendor posted WhatsApp details, where most transactions occur. The seller provided an guidebook and promised delivery within two days. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.
Product Details and Costs
Within these groups, posts display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how long a pen should last, sellers give conflicting answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram stated it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has already seen patients harmed by self-injection from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to possibly significant medical dangers”.
